David Y. Liu
Nessuna posizione attualmente
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
David Y.
Liu was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/03/2023 | 144 687 ( 0.25% ) | 4 M $ | 31/03/2024 |
Precedenti posizioni note di David Y. Liu
Società | Posizione | Fine |
---|---|---|
PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Trenovus, Inc. | Founder | 01/01/2012 |
FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01/01/2002 |
Harvard Medical School | Corporate Officer/Principal | 01/01/1986 |
Formazione di David Y. Liu
Michigan State University | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
FIBROGEN, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Trenovus, Inc. |
- Borsa valori
- Insiders
- David Y. Liu